secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001005286-23-000078
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical receives Nasdaq notice for late Q3 FY2023 10-Q filing
-------------------------------------------------------------------------

- Nasdaq notified Lifecore on April 13, 2023 of non-compliance with Listing Rule 5250(c)(1) due to delayed Form 10-Q for period ended Feb 26, 2023.
- Company has 60 days (by June 12, 2023) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant until October 10, 2023 to file the 10-Q.
- Notice has no immediate effect on trading of LFCR common stock; company intends to file promptly.
- This disclosure is required by Nasdaq Listing Rule 5810(b).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000078/0001005286-23-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000078/lndc-20230413.htm
  HTML page:      https://secwatch.observer/filing/0001005286-23-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer